Targeting PAK1 is effective against cutaneous squamous cell carcinoma in a syngenic mouse model
Open Access
- 19 June 2024
- journal article
- research article
- Published by Wiley in Cancer Science
- Vol. 115 (8) , 2839-2845
Abstract
By taking advantage of forward genetic analysis in mice, we have demonstrated that Pak1 plays a crucial role during DMBA/TPA skin carcinogenesis. Although Pak1 has been considered to promote cancer development, its overall function remains poorly understood. To clarify the functional significance of Pak1 in detail, we sought to evaluate the possible effect of an allosteric inhibitor against PAK1 (NVS‐PAK1‐1) on a syngeneic mouse model. To this end, we established two cell lines, 9AS1 and 19AS1, derived from DMBA/TPA‐induced squamous cell carcinoma (SCC) that engrafted in FVB mice. Based on our present results, NVS‐PAK1‐1 treatment significantly inhibited the growth of tumors derived from 9AS1 and 19AS1 cells in vitro and in vivo. RNA‐sequencing analysis on the engrafted tumors indicates that NVS‐PAK1‐1 markedly potentiates the epidermal cell differentiation and enhances the immune response in the engrafted tumors. Consistent with these observations, we found an expansion of Pan‐keratin‐positive regions and potentially elevated infiltration of CD8‐positive immune cells in NVS‐PAK1‐1‐treated tumors as examined by immunohistochemical analyses. Together, our present findings strongly suggest that PAK1 is tightly linked to the development of SCC, and that its inhibition is a promising therapeutic strategy against SCC.Keywords
Funding Information
- Japan Society for the Promotion of Science (JP19K07494, JP22K07012)
- Takeda Foundation
This publication has 17 references indexed in Scilit:
- Deletion of Pak1 in CD11c-Positive Cells Confers Resistance to Mouse Skin CarcinogenesisJournal of Investigative Dermatology, 2024
- Development and Utility of a PAK1-Selective DegraderJournal of Medicinal Chemistry, 2022
- Functional Polymorphism in Pak1–3′ Untranslated Region Alters Skin Tumor Susceptibility by Alternative PolyadenylationJournal of Investigative Dermatology, 2022
- Pak1 maintains epidermal stem cells by regulating Langerhans cells and is required for skin carcinogenesisOncogene, 2020
- Inhibition of PAK1 suppresses pancreatic cancer by stimulation of anti-tumour immunity through down-regulation of PD-L1Cancer Letters, 2020
- A Polymorphic Variant in p19Arf Confers Resistance to Chemically Induced Skin Tumors by Activating the p53 PathwayJournal of Investigative Dermatology, 2019
- The parathyroid hormone regulates skin tumour susceptibility in miceScientific Reports, 2017
- Targeting PAK1Biochemical Society Transactions, 2017
- Optimization of a Dibenzodiazepine Hit to a Potent and Selective Allosteric PAK1 InhibitorACS Medicinal Chemistry Letters, 2015
- Pak protein kinases and their role in cancerCancer and Metastasis Reviews, 2009